These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16480407)

  • 1. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study.
    Gui D; Mingrone G; Valenza V; Spada PL; Mutignani M; Runfola M; Scarfone A; Di Mugno M; Panunzi S
    Aliment Pharmacol Ther; 2006 Mar; 23(5):675-80. PubMed ID: 16480407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intramural administration of Botulinum Toxin A on gastric emptying and eating capacity in obese patients.
    Foschi D; Lazzaroni M; Sangaletti O; Corsi F; Trabucchi E; Bianchi Porro G
    Dig Liver Dis; 2008 Aug; 40(8):667-72. PubMed ID: 18420471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study.
    Foschi D; Corsi F; Lazzaroni M; Sangaletti O; Riva P; La Tartara G; Bevilacqua M; Osio M; Alciati A; Bianchi Porro G; Trabucchi E
    Int J Obes (Lond); 2007 Apr; 31(4):707-12. PubMed ID: 17006442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model.
    Coskun H; Duran Y; Dilege E; Mihmanli M; Seymen H; Demirkol MO
    Obes Surg; 2005 Sep; 15(8):1137-43. PubMed ID: 16197786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study.
    Júnior AC; Savassi-Rocha PR; Coelho LG; Spósito MM; Albuquerque W; Diniz MT; Paixão Ade M; Garcia FD; Lasmar LF
    Obes Surg; 2006 Mar; 16(3):335-43. PubMed ID: 16545166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of obesity by endoscopic gastric intramural injection of botulinum toxin A: a randomized clinical trial.
    Li L; Liu QS; Liu WH; Yang YS; Yan D; Peng LH; Li LY; Meng JY; Wang XD; Ke M
    Hepatogastroenterology; 2012 Sep; 59(118):2003-7. PubMed ID: 22193433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A for the treatment of delayed gastric emptying.
    Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
    Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study.
    Freund BJ; Schwartz M
    J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study.
    Topazian M; Camilleri M; De La Mora-Levy J; Enders FB; Foxx-Orenstein AE; Levy MJ; Nehra V; Talley NJ
    Obes Surg; 2008 Apr; 18(4):401-7. PubMed ID: 18286347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.
    Berthold HK; Unverdorben S; Degenhardt R; Unverdorben M; Gouni-Berthold I
    Obesity (Silver Spring); 2008 Oct; 16(10):2272-80. PubMed ID: 18719632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine.
    Vazquez Roque MI; Camilleri M; Clark MM; Tepoel DA; Jensen MD; Graszer KM; Kalsy SA; Burton DD; Baxter KL; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):829-37. PubMed ID: 17544870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and weight reduction do not influence gastric emptying and antral motility.
    Hutson WR; Wald A
    Am J Gastroenterol; 1993 Sep; 88(9):1405-9. PubMed ID: 8362840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial.
    de Moura EGH; Ribeiro IB; Frazão MSV; Mestieri LHM; de Moura DTH; Dal Bó CMR; Brunaldi VO; de Moura ETH; Nunes GC; Bustamante FAC; Dos Passos Galvão Neto M; Matuguma SE; Bernardo WM; Santo MA
    Obes Surg; 2019 Jan; 29(1):32-39. PubMed ID: 30120640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intragastric injection of botulinum toxin A for the treatment of obesity.
    Mittermair R; Keller C; Geibel J
    Obes Surg; 2007 Jun; 17(6):732-6. PubMed ID: 17879570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.
    Näslund E; King N; Mansten S; Adner N; Holst JJ; Gutniak M; Hellström PM
    Br J Nutr; 2004 Mar; 91(3):439-46. PubMed ID: 15005830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
    Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
    Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.